This Hyderabad Startup Is Turning

Health Checks into a 60-Second Habit

Blog main

Most Indians don’t ignore their health because they don’t care.

They ignore it because it feels too complicated.

  • Bulky diagnostic machines.
  • Confusing medical reports.
  • Doctor consultations that come after something goes wrong.

So people live with low energy, BP spikes, fatigue, and headaches without ever knowing what’s actually happening inside their bodies.

That everyday gap is what EYVA, a Hyderabad-based healthtech startup, is trying to close.

The Insight: Health Became Too Alien for Everyday People

“People alienate their health because everything around it is super-complicated.”

That observation by Sunil Maddikatla, Co-founder of EYVA, became the foundation of the company.

Sunil, along with co-founders Roshan Gupta and Srini Chandupatla, noticed a silent trend spreading across India — people who don’t look obese or sick, but are metabolically unhealthy inside.

  • Hidden visceral fat.
  • Insulin resistance.
  • Low metabolic efficiency.
  • Chronic fatigue with no diagnosis.

Most people try to fix this with gyms, smartwatches, or calorie counting. According to Sunil, that’s fixing the problem at the wrong place.

EYVA decided to go deeper.

The Product: A Non-Invasive Metabolic Health Device

EYVA is a pocket-sized, non-invasive metabolic health device that gives multiple health insights in under 60 seconds — without needles, pricks, or lab visits.

You simply :

  • Switch it on
  • Place your fingers
  • Get insights instantly

It tracks :

  • Glucose stability
  • Blood pressure
  • Oxygen levels
  • Heart rhythm
  • Metabolic score
  • Long-term health trends

The device works with the EYVA mobile app, which uses AI to personalise recommendations based on your body and habits.

From hydration reminders to workout timing suggestions — the focus is not panic, but practical daily guidance.

Why This Wasn’t Built Overnight

EYVA didn’t rush to market.

It took nearly five years of R&D before commercialisation.

Timeline :

  • Company founded in 2017
  • CES Las Vegas reveal in 2022
  • Alpha & beta testing phases
  • Public launch in mid-2023

Today :

  • ~20,000 users
  • ~3,500 daily active users
  • Average daily usage: 6–9 minutes

That level of engagement comes only when people trust the product.

AI That Learns You, Not Just Your Numbers

EYVA’s AI doesn’t act on one scan.

It takes around 30 initial scans to understand :

  • Your physiology
  • Behaviour patterns
  • Lifestyle context

The system focuses on health trends,not one-off readings.

Even then, EYVA claims about 85% accuracy when benchmarked against WHO gold-standard diagnostic machines — notable for a non-invasive consumer device.

Under the hood :

  • Neural networks for scoring
  • Generative AI (GPT, Gemini, Claude) for explanations
  • Strict in-house guardrails for reliability

In short : AI that informs, not overwhelms.

Made in India, Built to Last

EYVA is fully designed and manufactured in India.

Some key details :

  • 99% recyclable
  • Anodised aluminium body (laptop-grade durability)
  • Drop-tested for real-world use
  • FDA registered
  • CDSCO compliant in India

Manufacturing is done through 15+ contract partners across Hyderabad, Bengaluru, and nearby hubs.

Early users came from a 7,000-person waitlist and included diplomats, bureaucrats, professionals, and global Indians from the US and Singapore.

A Business Model Designed for Indian Families

The device is priced at ₹16,650 and supports four user profiles.

Why?
Because Indian households don’t buy four devices if one can do the job.

EYVA sells only via its own website and app — a conscious decision to stay close to early adopters and feedback.

Each purchase includes :

  • 1.5 years of unlimited app access
  • Optional advanced features (coming soon) at very low annual pricing

The aim is long-term adoption, not subscription pressure.

Team, Traction, and Capital

  • Core team: 25
  • Extended team: ~30
  • Tech team: 6 (AI + electronics)
  • Offices: Hyderabad, Delhi, Ahmedabad

Funding :

  • ~$3 million raised (up to pre-Series A)
  • Backed by Indian & global angels and family offices
  • Supported by T-Hub
  • Angels include leaders from Samsung & Microsoft ecosystems

Revenue :

  • FY24: ~$2.5 million
  • FY25: ~2.5x growth

Quiet execution. Real traction.

Competition and Market Reality

EYVA is not meant for :

  • Type 1 diabetics
  • People under 18
  • Extremely high-risk medical cases

Globally, users would need multiple devices — glucose trackers, BP monitors, wearables — to replicate what EYVA offers in one.

EYVA’s goal is to become a single metabolic health platform, not a fragmented dashboard.

India’s digital health market is projected to grow at a 19–25% CAGR, and EYVA plans to onboard 200,000 users in the next three years.

What’s Next: Global and Corporate Expansion

EYVA has already been showcased in Australia, including at the NSW Parliament.

Upcoming plans :

  • Australia launch
  • US entry next
  • Corporate wellness (B2B2C) partnerships in India
  • Global go-to-market partners
  • A new prototype for busy individuals needing quicker, deeper energy insights

Vyapaarवाणी Takeaway

EYVA’s story isn’t about gadgets.
It’s about simplifying something people avoided because it felt too complex.

Key lessons for builders :

  • Solve root problems, not surface symptoms
  • Build for Indian behaviour, not imported assumptions
  • Trust is earned through patience, not speed
  • Hardware + AI needs discipline, not hype

In a country drowning in health data but starving for understanding, EYVA is betting on one simple belief :

Health should feel empowering, not intimidating.

And that makes this startup worth watching.

Connect With Us

For Any Inquiries Or Assistance, Please Feel Free To Reach Out. Our Team Is Here To Support You And Will Respond At The Earliest Convenience